This could include the changes in insulin sensitivity and glycemic control, given that impairments in these parameters have been implicated in explaining the lower fasting concentrations and blunted postprandial responses of appetite-related hormones in individuals with overweight/obesity [69,70]. The gene discussed is INS; the disease is Obesity.